Valneva

Valneva Diluted EPS

The Diluted Earnings per Share of Valneva (VLA.PA) as of Oct 25, 2026 is -0.66 EUR. In the previous year, Diluted Earnings per Share was -0.08 EUR — a change of 780.81% (lower).

Diluted EPS

-0.66EUR

YoY

780.81%

Last updated:

Diluted Earnings per Share of Valneva is 2025 -0.66 EUR. Diluted Earnings per Share of Valneva was 2024 -0.08 EUR. It decreases by 780.81% lower compared to the previous year.

The Valneva Diluted EPS history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Diluted EPS
Date
Diluted EPS
Jan 1, 2018
0.04 EUR
Jan 1, 2019
-0.02 EUR
Jan 1, 2020
-0.70 EUR
Jan 1, 2021
-0.73 EUR
Jan 1, 2022
-1.04 EUR
Jan 1, 2023
-0.73 EUR
Jan 1, 2024
-0.08 EUR
Jan 1, 2025
-0.66 EUR
The Valneva Diluted EPS history
YEARDiluted EPSYoY
-0.66EUR+780.81%
-0.08EUR-89.68%
-0.73EUR-29.50%
-1.04EUR+42.44%
-0.73EUR+3.96%
-0.70EUR+3,592.26%
-0.02EUR-153.43%
0.04EUR-128.43%
-0.12EUR-76.66%
-0.53EUR+138.56%
-0.22EUR-21.52%
-0.29EUR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valneva Stock analysis

What does Valneva do? Valneva SE is a biopharmaceutical company specializing in the development, production, and marketing of vaccines for humans and animals. The company was founded in 2013 through the merger of French biotech company Vivalis and Austrian biotech company Intercell. Valneva focuses on developing vaccines for infectious diseases with a significant global burden but limited commercial demand. They work closely with governments and international organizations to improve access to their vaccines in developing countries. Valneva also has a strong presence in the animal vaccine market, producing vaccines for diseases in livestock and pets. They have developed and marketed several vaccines, including Ixiaro for Japanese encephalitis and VLA15, a vaccine candidate for Lyme disease. Overall, Valneva is an international company with an impressive pipeline of vaccine candidates and a commitment to addressing global health needs. Valneva is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Valneva stock

Diluted Earnings per Share of Valneva is -0.66 EUR in 2025.

Diluted Earnings per Share of Valneva changed from -0.08 EUR to -0.66 EUR, representing a 780.81% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Diluted Earnings per Share Valneva since 2006 – with annual values, charts, and detailed analysis.

Diluted EPS accounts for all potential shares from options, warrants, and convertible securities. It provides a more conservative per-share earnings measure.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Valneva

All Key Metrics — Valneva